Asterias biotherapeutics, inc. (AST)
Balance Sheet / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
ASSETS
CURRENT ASSETS
Cash and cash equivalents

6,424

9,217

10,519

13,166

8,620

11,875

18,059

19,800

17,926

21,469

7,568

11,183

12,645

15,636

7,421

3,076

5,025

12,861

325

2,171

91

0

Marketable equity securities

6,161

5,588

-

8,329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivables

2,429

-

-

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable equity securities

-

-

8,281

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities, at fair value

-

-

-

-

12,095

13,141

14,441

15,269

15,999

10,745

11,949

17,006

11,561

13,990

19,152

14,374

12,100

11,754

29,289

32,052

-

0

BioTime warrants to be distributed to holders of Series A shares (see Note 2)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,572

7,973

12,245

15,568

-

0

Grant receivable

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

118

-

-

-

0

-

-

Landlord receivable

-

-

-

-

-

-

-

-

0

0

0

567

-

-

-

378

-

-

-

-

-

-

Landlord receivable

-

-

-

-

-

-

-

-

-

-

-

-

1,525

2,771

277

-

-

-

-

0

-

-

Prepaid expenses and other current assets

748

1,083

1,149

1,187

1,214

1,349

1,664

1,921

1,989

1,616

1,157

1,033

830

627

510

438

352

283

389

340

224

4

Total current assets

15,762

15,888

19,949

22,716

21,929

26,365

34,164

36,990

35,914

33,830

20,674

29,789

26,561

33,024

27,361

18,384

25,050

32,872

42,250

50,131

315

4

NONCURRENT ASSETS
Intangible assets, net

13,430

14,101

14,772

15,444

16,116

16,787

17,458

18,130

-

-

-

20,816

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

18,802

19,473

20,145

-

21,488

22,159

22,830

23,502

26,115

26,840

27,566

28,291

-

0

Property, plant and equipment, net

598

4,030

4,282

4,543

4,760

4,999

5,210

5,475

5,212

5,372

5,539

5,756

843

940

928

1,045

1,252

1,389

1,426

1,460

1,480

0

Construction in progress

-

-

-

-

-

-

-

-

-

-

-

-

4,603

3,416

606

406

-

-

-

0

-

-

Investment in affiliates

-

-

-

-

-

-

-

-

0

0

0

416

416

416

415

416

415

415

415

415

-

0

Deferred tax asset

-

-

-

-

-

-

-

-

9,956

8,150

7,870

-

-

-

-

0

-

-

-

-

-

-

Other assets

24

324

324

389

515

411

389

415

419

419

422

457

460

361

360

361

360

360

354

54

-

0

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54

-

Total noncurrent assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,143

29,006

29,762

-

1,534

0

TOTAL ASSETS

29,814

34,343

39,327

43,092

43,320

48,562

57,221

61,010

70,303

67,244

54,650

57,234

54,371

60,316

52,503

44,114

53,194

61,879

72,013

80,353

1,850

4

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Amount due to BioTime, Inc.

-

-

-

-

0

0

0

288

463

0

833

530

264

166

863

615

406

5,433

3,146

2,064

6,392

761

Accounts payable

-

-

-

-

311

408

737

1,076

640

251

1,906

747

399

1,389

1,132

737

386

253

486

567

-

0

Accounts payable and accrued expenses

2,017

1,827

1,381

2,958

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

353

-

Deferred rent and lease incentives, current

402

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

2,058

1,604

1,848

2,495

981

1,544

1,152

1,183

1,631

580

589

430

140

274

216

95

234

0

Capital lease liability, current

7

7

7

7

7

7

7

7

7

7

7

7

-

-

-

0

-

-

-

-

-

-

Lease liability, current

0

-

-

556

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, current

-

597

576

-

-

-

-

484

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

Deferred grant income

-

-

-

-

0

0

291

2,185

1,392

3,249

2,270

2,513

1,869

1,877

1,474

0

-

-

-

-

-

-

Deferred tax liabilities, current portion

-

-

-

-

-

-

-

-

5,393

3,606

3,947

-

3,729

4,578

6,385

4,713

-

-

-

0

-

-

Other current liability

-

-

-

-

-

-

-

-

-

182

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

2,426

2,431

1,964

3,521

2,376

2,019

2,883

6,535

8,876

8,839

10,115

4,980

7,892

8,590

10,445

6,497

8,504

13,936

16,094

18,295

6,980

761

NONCURRENT LIABILITIES
Warrant liability

703

872

1,238

2,757

5,262

5,767

5,711

8,665

8,376

4,380

-

0

-

-

-

-

7,572

7,973

12,245

15,568

-

0

Deferred revenue

1,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease liability, noncurrent

9

11

12

14

16

18

18

20

21

22

25

26

-

-

-

0

-

-

-

-

-

-

Deferred rent and lease incentives, noncurrent

1,171

-

-

316

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, noncurrent

0

-

-

2,941

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities, net

-

-

-

-

-

-

-

-

5,963

6,305

6,676

2,550

-

-

-

4,514

-

-

-

-

-

-

Deferred tax liabilities, net of current portion and deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-128

-1,690

-2,930

-

-10,787

-14,244

-6,928

-8,277

-

0

Deferred rent

-

325

320

-

310

296

281

266

251

227

203

179

94

36

34

94

-

-

-

0

-

-

Lease liability, noncurrent

-

2,632

2,789

-

-

-

-

3,496

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability

-

-

-

-

3,624

3,747

3,866

-

4,090

4,197

-

4,400

-

-

-

-

-

-

-

-

-

-

Lease liability

-

-

-

-

-

-

-

-

-

-

4,300

-

4,089

3,331

560

378

-

-

-

0

-

-

TOTAL LIABILITIES

5,309

6,271

6,323

9,549

11,588

11,847

12,759

18,982

27,577

23,970

21,319

12,135

12,203

13,647

13,971

11,483

19,292

28,180

23,022

26,573

6,980

761

Commitments and contingencies (see Note 8)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

STOCKHOLDERS' EQUITY
Preferred Stock, $0.0001 par value, authorized 5,000 shares; none issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common Stock, $0.0001 par value, authorized 125,000 shares of Series A Common Stock and 75,000 shares of Series B Common Stock; 55,659 and 54,051 shares of Series A Common Stock issued and outstanding at September 30, 2018 and December 31, 2017, respectively; no shares of Series B Common Stock issued and outstanding at September 30, 2018 and December 31, 2017

6

6

5

5

5

5

5

5

5

5

4

4

4

4

3

3

3

3

3

3

0

0

Additional paid-in capital

156,760

155,873

153,824

152,136

141,132

138,659

136,379

126,829

117,452

112,067

96,302

92,900

87,829

87,243

72,134

66,367

66,851

65,312

80,109

79,850

493

51

Accumulated other comprehensive loss

0

0

0

-6,498

-3,853

-3,206

-1,907

-1,078

-348

-5,063

-4,399

434

-2,331

-752

2,603

-503

-3,043

-3,389

-5,696

-2,934

-

0

Accumulated deficit

-132,261

-127,807

-120,825

-112,100

-105,552

-98,743

-90,015

-83,728

-74,383

-63,735

-58,576

-48,239

-43,334

-39,826

-36,208

-33,236

-29,909

-28,227

-25,425

-23,138

-5,573

-758

Subscription receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-50

-50

Total stockholders' equity

24,505

28,072

33,004

33,543

31,732

36,715

44,462

42,028

42,726

43,274

33,331

45,099

42,168

46,669

38,532

32,631

33,902

33,699

48,990

53,780

-5,130

-757

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

29,814

34,343

39,327

43,092

43,320

48,562

57,221

61,010

70,303

67,244

54,650

57,234

54,371

60,316

52,503

44,114

53,194

61,879

72,013

80,353

1,850

4